JC virus urinary excretion and seroprevalence in natalizumab-treated MS patients
The risk of developing progressive multifocal leukoencephalopathy (PML), as a consequence of infection/reactivation with JC virus (JCV), is consistent in natalizumab-treated multiple sclerosis (MS) patients, with 430 cases of PML reported so far.......... Read More - http://www.ms-uk.org/tysabri
JC virus urinary excretion and seroprevalence.....
JC virus urinary excretion and seroprevalence.....
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 2502 Views
-
Last post by NHE
-
- 1 Replies
- 432 Views
-
Last post by Leonard
-
- 3 Replies
- 499 Views
-
Last post by Leonard
-
- 2 Replies
- 1078 Views
-
Last post by DIM
-
- 4 Replies
- 2504 Views
-
Last post by NHE
-
- 0 Replies
- 1379 Views
-
Last post by Tif
-
- 0 Replies
- 1982 Views
-
Last post by Tif
-
- 0 Replies
- 1745 Views
-
Last post by Tif
-
- 0 Replies
- 1497 Views
-
Last post by Tif